PHARMACEUTICAL COMPOSITIONS FOR THE TRANSMUCOSAL DELIVERY OF THERAPEUTIC PEPTIDES AND PROTEINS

作者: Werle Martin , Föger Florian

DOI:

关键词:

摘要: The present invention relates to a pharmaceutical composition for transmucosal administration, comprising peptide or protein drug in combination with an excipient pKa value of 12 higher (e.g., arginine free base, EDTA tetrasodium salt, trisodium phosphate, tris(hydroxymethyl)aminomethane, lysine, calcium hydroxide).

参考文章(45)
Samir Suresh Mitragotri, Vijay M. K. Murthy, Baruch Z. Harris, Jonathan Robert Behr, Robert Samuel Langer, Hila Esptein-Barash, Howard Brian Rosen, David Adam Steinberg, Rodney Pearlman, Mucoadhesive devices for delivery of active agents ,(2013)
Niels C. Kaarsholm, Per Olaf Huusfeldt, Liselotte Bjerre Knudsen, Helle Birk Olsen, Per Franklin Nielsen, Soren Erik Bjorn, Glp-1 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates ,(1999)
Jeppe Sturis, Kjeld Madsen, Nils Langeland Johansen, Thomas Kruse Hansen, Jesper Lau, Novel glp-1 compounds ,(2004)
Bernd Henkel, Torsten Haack, Andreas Evers, Martin Bossart, Siegfried Stengelin, Dieter Kadereit, Michael Wagner, Dual glp-1/glucagon receptor agonists ,(2014)
Nobuo Ida, Kozo Takayama, Reiji Nishio, Mariko Morishita, Cell-penetrating peptides ,(2010)
Peter G. M. Wuts, Theodora W. Greene, Greene's Protective Groups in Organic Synthesis ,(2006)